MKI67 and neoplasm: In addition, treatment with HuNbTROP2-HSA-MMAE inhibited tumor cell proliferation in a dose-dependent manner, as evidenced by a gradual decrease in the proportion of Ki-67-positive cells (Fig. 6D).